123 related articles for article (PubMed ID: 6824024)
21. [Prediction of the recurrence of squamous cell carcinoma of the uterine cervix by monitoring serum TA-4].
Oishi T; Maruo T; Yamasaki M; Mochizuki M
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):799-806. PubMed ID: 3598275
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
25. Studies on the special tumor marker of cervical cancer of the uterus.
Kato H
Semin Surg Oncol; 1987; 3(1):55-63. PubMed ID: 3544141
[TBL] [Abstract][Full Text] [Related]
26. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation].
Roszak A; Bratos K; Górny A; Mackiewicz A
Ginekol Pol; 1996 Sep; 67(9):457-9. PubMed ID: 9289466
[TBL] [Abstract][Full Text] [Related]
28. [Determination of the SCC antigen in the serum of patients with cervical cancer].
Crombach G; Würz H; Bolte A
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
[TBL] [Abstract][Full Text] [Related]
29. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
[TBL] [Abstract][Full Text] [Related]
30. Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line.
Hussa RO; Maruo T; Strobel JL; Pattillo RA; Mochizuki M
Obstet Gynecol; 1986 Jun; 67(6):802-5. PubMed ID: 2422615
[TBL] [Abstract][Full Text] [Related]
31. Blood group antigen expression and prognosis in squamous cell carcinoma of the uterine cervix.
Lindgren A; Stendahl U; Brodin T; Lundblad A; Sällström J; Busch C
Anticancer Res; 1986; 6(2):255-8. PubMed ID: 2423015
[TBL] [Abstract][Full Text] [Related]
32. The use of a tumor antigen TA-4 for the management of squamous cell carcinoma.
Kato H; Tamai K; Nagaya T; Nagai M; Torigoe T
Cancer Detect Prev; 1985; 8(1-2):155-9. PubMed ID: 4064035
[TBL] [Abstract][Full Text] [Related]
33. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical demonstration of tumor antigen TA-4 in gynecologic tumors.
Ueda G; Inoue Y; Yamasaki M; Inoue M; Tanaka Y; Hiramatsu K; Saito J; Nishino T; Abe Y
Int J Gynecol Pathol; 1984; 3(3):291-8. PubMed ID: 6389386
[TBL] [Abstract][Full Text] [Related]
35. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of tumor associated antigen in squamous cell carcinoma of cervix by immunodiffusion.
Tsai WS; Chiang WT; Wei PY; Alexander ER
Taiwan Yi Xue Hui Za Zhi; 1976 Sep; 75(9):489-96. PubMed ID: 827599
[No Abstract] [Full Text] [Related]
37. Does preoperative serum squamous cell carcinoma antigen level predict occult extracervical disease in patients with stage Ib invasive squamous cell carcinoma of the cervix?
Patsner B; Orr JW; Allmen T
Obstet Gynecol; 1989 Nov; 74(5):786-8. PubMed ID: 2812656
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma antigen (TA-4) in penile carcinoma.
Wishnow KI; Johnson DE; Fritsche H
Urology; 1990 Oct; 36(4):315-7. PubMed ID: 2219609
[TBL] [Abstract][Full Text] [Related]
39. Correlative light and immunohistological study of the HCG-like antigen in the squamous cell carcinoma of the human uterine cervix.
Yamasaki M; Ueda G; Inoue M; Tanaka Y; Tanizawa O; Kurachi K
Nihon Sanka Fujinka Gakkai Zasshi; 1981 Jan; 33(1):151-4. PubMed ID: 7014735
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of leukocyte adherence by potassium chloride extract of allogeneic squamous cell carcinoma of the human uterine cervix.
Dini MM; Lenzi L; Faiferman I
Am J Reprod Immunol (1980); 1983 Jun; 3(4):188-90. PubMed ID: 6881415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
